Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2005
09/09/2005WO2005083084A1 Intercalating triplex forming oligonucleotide derivatives and process for the preparation thereof
09/09/2005WO2005083083A2 Materials and methods for treatment of allergic disease
09/09/2005WO2005083082A1 Method for producing l-amino acids by means of recombinant coryneform bacteria with reduced activity asur regulators
09/09/2005WO2005083081A1 Improved nuclease inhibitor cocktail
09/09/2005WO2005083080A1 Plasmid purification
09/09/2005WO2005083079A1 Generation of recombinant genes in prokaryotic cells by using two extrachromosomal elements
09/09/2005WO2005083078A1 Method, chip, device and system for extraction of biological materials
09/09/2005WO2005083077A1 Process for producing amino acid
09/09/2005WO2005083076A1 Immune stimulant oligonucleotide inducing interferon alpha
09/09/2005WO2005083075A1 Novel gene participating in epidermal differentiation and use thereof
09/09/2005WO2005083074A1 Tumor antigen peptides
09/09/2005WO2005083073A1 Dna enzyme and method of controlling the activity thereof
09/09/2005WO2005083072A1 Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli
09/09/2005WO2005083071A1 Polynucleotide participating in rheumatoid arthritis and utilization of the same
09/09/2005WO2005083070A1 Pharmaceutical composition for lowering blood sugar level
09/09/2005WO2005083062A1 Cell vaccine
09/09/2005WO2005083059A1 Compositions and methods for making insulin-producing cells
09/09/2005WO2005083054A1 Method and device for thermal conditioning of a cell
09/09/2005WO2005083053A2 Method for producing unsaturated omega-3 fatty acids in transgenic organisms
09/09/2005WO2005082933A1 Novel chimeric protein, gene encoding the same, and means of judging leukemia using the gene and the protein
09/09/2005WO2005082932A2 Compositions and methods using rna interference for control of nematodes in plants
09/09/2005WO2005082931A1 Novel phytochrome-interacting protein and a use thereof
09/09/2005WO2005082930A2 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005WO2005082923A1 Novel method of synthesizing nucleic acid without protecting nucleotide bases
09/09/2005WO2005082458A1 Muc1 antagonist enhancement of death receptor ligand-induced apoptosis
09/09/2005WO2005082422A1 Combination of ad-p53 and chemotherapy for the treatment of tumours
09/09/2005WO2005082412A1 Drug for treating and preventing cancer
09/09/2005WO2005082137A1 Mammal for studying dcis and the effect of inactivated tumor suppressors
09/09/2005WO2005082098A2 Polony fluorescent in situ sequencing beads
09/09/2005WO2005082088A2 Functional genomics and gene trapping in haploid or hypodiploid cells
09/09/2005WO2005082077A2 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
09/09/2005WO2005081854A2 Egf receptor epitope peptides and uses thereof
09/09/2005WO2005081847A2 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
09/09/2005WO2005081714A2 Use of interfering rna in the production of transgenic animals
09/09/2005WO2005072223A3 Engineered proteins, and methods of making and using
09/09/2005WO2005063007A8 Non-human mammal comprising a modified serca2 gene and methods, cells, genes, and vectors thereof
09/09/2005WO2005062947A3 Methods and compositions for identifying rna-binding proteins
09/09/2005WO2005062812A3 A rAAV-BASED SYSTEM FOR SOMATIC CELL GENE DISRUPTION
09/09/2005WO2005060997A3 Medicament comprising inhibitors of long pentraxin ptx3
09/09/2005WO2005059156A3 Nucleic acid probes and broad-range primers from regions in dna directed rna polymerase subunit b genes, and methods in which they are used
09/09/2005WO2005058957A3 Ztnf 12, a tumor necrosis factor
09/09/2005WO2005052581A3 Spherical and magnetic silicagel carriers having an increase surface for purifying nucleic acids
09/09/2005WO2005049853A3 Compositions and methods for screening pro-apoptotic compounds
09/09/2005WO2005049841B1 Insect resistance using inhibition of gene expression
09/09/2005WO2005046614A3 System for treating and preventing breast cancer
09/09/2005WO2005042714A3 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
09/09/2005WO2005037222A3 Recombinant intracellular pathogen immunogenic compositions and methods for use
09/09/2005WO2005034733A3 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia
09/09/2005WO2005030802A3 Antigens for an east coast fever vaccine
09/09/2005WO2005027979A3 Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
09/09/2005WO2005026362A3 Lymphatic and blood endothelial cell genes
09/09/2005WO2005026359A3 The use of eukaryotic genes affecting spindle formation or microtubule function during cell division for diagnosis and treatment of proliferative diseases
09/09/2005WO2005014782A3 Double-stranded ribonucleic acid with increased effectiveness in an organism
09/09/2005WO2005002325A3 Generation of plants with improved drought tolerance
09/09/2005WO2005000898A3 Use of hydrophobic-interaction-chromatography or hinge-region modifications for the production of homogeneous antibody-solutions
09/09/2005WO2005000320A3 Use of double-stranded ribonucleic acid for inducing cell lysis
09/09/2005WO2005000220A8 Method for treating cancer by vector-mediated delivery of one or more anti-angiogenic or pro-apoptotic genes
09/09/2005WO2005000198A3 An intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same
09/09/2005WO2004108889A3 Hybrid antibodies
09/09/2005WO2004089189B1 Minimally-invasive imaging of viral gene therapy and presurgical applications thereof
09/09/2005WO2004087862A3 Tak1-mediated inhibition of osteogenesis
09/09/2005WO2004085608A3 Methods for high throughput elucidation of transcriptional profiles and genome annotation
09/09/2005WO2004078981A8 Hyperactive, non-phosphorylated, mutant transposases of mariner mobile genetic elements
09/09/2005WO2004076635A3 Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
09/09/2005WO2004067745A8 Gene expression inducing fusion protein and method for controlling gene expression induction
09/09/2005WO2004061113A8 Adeno-associated virus mediated b7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers
09/09/2005WO2003093421A3 Methods and compositions for use in homologous recombination
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
09/09/2005WO2001018253A9 Gene manipulation method using homologous recombination
09/09/2005CA2799245A1 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof
09/09/2005CA2558726A1 Method for producing unsaturated omega-3 fatty acids in transgenic organisms
09/09/2005CA2558581A1 Novel method for the synthesis of nucleic acid without protecting base moiety
09/09/2005CA2558178A1 Recombinant perforin, expression and uses thereof
09/09/2005CA2557841A1 Polony fluorescent in situ sequencing beads
09/09/2005CA2557729A1 Reduction of spontaneous mutation rates in cells
09/09/2005CA2557644A1 Plants modified with mini-chromosomes
09/09/2005CA2557597A1 A novel cofactor that modulates steroid receptor activities
09/09/2005CA2557500A1 Methods and compositions for the treatment and prevention of hiv infection using trim5.alpha.
09/09/2005CA2557499A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
09/09/2005CA2557490A1 Generation of recombinant genes in prokaryotic cells by using two extrachromosomal elements
09/09/2005CA2557486A1 Method, chip, device and system for extraction of biological materials
09/09/2005CA2557375A1 Plants having increased yield and method for making the same
09/09/2005CA2557326A1 Combination of ad-p53 and chemotherapy for the treatment of tumours
09/09/2005CA2556927A1 Methods for enhancing insect resistance in plants
09/09/2005CA2556729A1 Muc1 antagonist enhancement of death receptor ligand-induced apoptosis
09/09/2005CA2556632A1 Egf receptor epitope peptides and uses thereof
09/09/2005CA2556436A1 Process for preparing anit-a.beta. antibody
09/09/2005CA2555413A1 An immunoreactive 38-kda ferric binding protein of ehrlichia canis and uses thereof
09/09/2005CA2555251A1 E.coli o157:h7 c1-1nh-binding protein and methods of use
09/09/2005CA2555245A1 Antisense oligonucleotide modulation of stat3 expression
09/09/2005CA2555230A1 Systems and methods for clonal expression in plants
09/09/2005CA2555105A1 Potent mucosal immune response induced by modified immunomodulatory oligonucleotides
09/09/2005CA2552351A1 Method for determination and quantification of radiation or genotoxin exposure
09/09/2005CA2546853A1 Use of interfering rna in the production of transgenic animals
09/09/2005CA2497087A1 Novel genes encoding proteins involved in proanthocyanidin synthesis
09/08/2005US20050198713 Methods for developing conifer somatic embryos
09/08/2005US20050198712 Glutamine-rich maize seed protein and promoter
09/08/2005US20050198711 Indeterminate gametophyte 1 (ig1), mutations of ig1, orthologs of ig1, and uses thereof
09/08/2005US20050198710 Method of improving soybean protein color by reducing levels of flavonol
09/08/2005US20050198707 Expression vector comprisig nucleotide sequences coding arsenate reductase for use in detoxification of metal ions in soil; bioremediation
1 ... 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 ... 4023